How Quickly Does Untreated Pulmonary MAC Disease Progress?

Untreated pulmonary Mycobacterium avium complex (MAC) disease does not progress at a single, predictable speed. For some people, the condition can remain stable for years or even improve without antibiotics, while for others, it causes rapid lung damage over months to a few years ^[1][2][3]. Because MAC medications require a long commitment and carry side effects, doctors often rely on “watchful waiting” (or active surveillance) for carefully selected, stable patients ^[4][5].

Choosing to monitor the disease rather than immediately starting antibiotics can feel uncertain and difficult. However, active surveillance does not mean doing nothing. It is a shared, planned approach where you and an experienced clinician track specific markers to catch progression early. Predicting how fast your disease might worsen depends heavily on the specific type of disease you have, your overall health, and the burden of organisms in your lungs.

The Form of MAC Disease Matters

How your lungs look on a computed tomography (CT) scan is one of the strongest indicators of how fast the disease might move. Some patients have a mix of these patterns, but they generally fall into two categories:

• Nodular-bronchiectatic disease: This is the most common and typically the slowest-moving form of MAC. It involves small nodules and widened, scarred airways (bronchiectasis). In observational studies of patients with this milder form who deferred treatment, the disease usually progressed very slowly. For example, over roughly 4 to 7 years of observation, the vast majority of patients in one cohort showed gradual worsening on CT scans ^[1][6]. In specific studies tracking noncavitary disease, it took an average of about 4.2 years for the infection to show up in both lungs (if it started in one) ^[3], and roughly 3.7 years for nearly 9% of these patients to develop new lung cavities ^[2]. Interestingly, in one observational study, about half of the untreated patients with stable nodular-bronchiectatic disease had their sputum cultures become negative without medication (a process called spontaneous culture conversion) ^[7][8]. However, culture conversion does not mean the disease is permanently cured, as bronchiectasis remains and reinfection can occur.
• Fibrocavitary disease: This form involves larger areas of lung scarring and cavities (holes in the lung tissue). Fibrocavitary MAC tends to progress much faster and is associated with more rapid lung damage and a poorer overall prognosis (expected outlook) ^[9][8][10]. Doctors rarely recommend watchful waiting for this form of the disease; instead, immediate treatment is usually strongly considered.

Risk Factors for Faster Progression

While every patient is different, several factors increase clinical concern and are associated with a higher likelihood of the disease worsening rapidly ^[8][11][12]:

• Positive AFB smears: An AFB (acid-fast bacilli) smear is a test that detects mycobacteria under a microscope. A positive smear suggests a higher burden of organisms in your lungs ^[8][13]. While a culture is needed to definitively identify the bacteria as MAC, a persistently positive smear is a strong marker that the disease may progress and require treatment.
• Extensive lung involvement: If your initial imaging shows that the disease affects many areas of your lungs (such as more than three lobes), it is more likely to worsen ^[11][7].
• Low body weight or nutritional decline: Having a low body weight (such as a BMI under 18.5 or 20) or experiencing unintentional weight loss are significant risk factors for MAC progression ^[14][15][8]. Poor nutritional status makes it harder for your immune system to keep the infection in check.
• Systemic (whole-body) symptoms: Experiencing fevers, night sweats, or severe weight loss are signs that the disease is taking a larger toll on your body ^[16][17][7]. These symptoms warrant prompt clinical review, though they can also be caused by other conditions.
• Other lung conditions: Having co-existing conditions like emphysema or interstitial lung disease (a group of disorders that cause scarring of the lungs) is associated with poorer overall outcomes and may complicate how your MAC progresses ^[18][19].

How Doctors Monitor for Progression

Active surveillance requires a customized plan. Because symptoms alone don’t always tell the whole story, your medical team will use a combination of tools to monitor your MAC ^[4][5]:

• Serial Sputum Cultures: You will be asked to provide sputum (phlegm) samples regularly. Doctors look at whether the cultures remain positive over time or if they become negative ^[20][8]. Note that a single positive or negative culture does not definitively prove progression or improvement.
• Chest Imaging: Routine CT scans or X-rays allow your doctor to look for structural changes, such as new cavities or worsening bronchiectasis ^[1][6]. The frequency depends on your individual risk and the need to limit radiation exposure.
• Pulmonary Function Tests (PFTs): These breathing tests track changes in your lung capacity, often measured as FEV1 (the amount of air you can forcefully exhale in one second) and FVC (the total amount of air you can exhale). A reproducible decline is a measurable sign of physiologic worsening and warrants evaluation, though PFTs can also be affected by asthma, effort, or other lung conditions ^[21][8].
• Weight and Nutrition Tracking: Since dropping body weight is closely tied to disease progression, your doctor will monitor your weight and BMI ^[12][8].
• Activity Levels: A decrease in your exercise tolerance or ability to do daily activities can be a subtle sign that your lung health is changing.

Note: Even without antibiotics, active surveillance often includes airway-clearance techniques, optimizing your nutrition, and managing other lung conditions.

When to Seek Prompt Medical Attention

If you are on a watchful waiting plan, do not wait for your next scheduled appointment if you experience severe or rapid changes. Contact your clinical team or seek urgent care if you develop:

• Coughing up more than a small streak of blood (hemoptysis), or recurrent bleeding
• Rapidly worsening shortness of breath or breathlessness at rest
• New or worsening chest pain
• High or persistent fevers
• Confusion, faintness, or a marked drop in your oxygen levels (if you monitor them at home)